Session Details

S010 Infectious Diseases

Fri, Mar 8, 9:00 AM - 12:00 PM
Room 29B
3 CME Available Symposium
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This course will review recent and emerging developments related to the field of cutaneous infections, including both adult and pediatric patients. Emerging viral illnesses, maladies from the southern hemisphere and new-fungal pathogens will be highlighted. Resurgent syphilis will be discussed.

LEARNING OBJECTIVES

1.

Identify and recognize an emerging fungal infections.

2.

Recognize current pediatric ID threats.

3.

Employ dermoscopy as an ID diagnostic tool.

SCHEDULE

5:00 PM

Viral disease update

Stephen K Tyring, MD, PhD, FAAD

5:30 PM

Dermoscopy in infectious disease

Michelle B Tarbox, MD, FAAD

6:00 PM

Trichophyton indotineae

Aditya K. Gupta, MD, PhD, FAAD

6:20 PM

Pediatric ID Update

Sheila Fallon Friedlander, MD

6:55 PM

Maladies from Central/South America

Jose Dario Martinez, MD, IFAAD

7:30 PM

Syphilis is back

Theodore Rosen, MD, FAAD

SPEAKERS

Sheila Fallon Friedlander, MD

Sheila Fallon Friedlander, MD

Aditya K. Gupta, MD, PhD, FAAD

Aditya K. Gupta, MD, PhD, FAAD

Jose Dario Martinez, MD, IFAAD

Jose Dario Martinez, MD, IFAAD

Theodore Rosen, MD, FAAD

Theodore Rosen, MD, FAAD

Michelle B Tarbox, MD, FAAD

Michelle B Tarbox, MD, FAAD

Stephen K Tyring, MD, PhD, FAAD

Stephen K Tyring, MD, PhD, FAAD

SPEAKER DISCLOSURES

Sheila Fallon Friedlander, MD

No financial relationships exist with ineligible companies.

Aditya K. Gupta, MD, PhD, FAAD

Bausch Health – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Emblation Limited – Investigator(Grants/Research Funding); Moberg Derma – Consultant(Fees); Ortho Dermatologics – Consultant(Fees);

Jose Dario Martinez, MD, IFAAD

No financial relationships exist with ineligible companies.

Theodore Rosen, MD, FAAD

No financial relationships exist with ineligible companies.

Michelle B Tarbox, MD, FAAD

Castle Biosciences – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding);

Stephen K Tyring, MD, PhD, FAAD

AbbVie – Investigator(Grants/Research Funding), Speaker(Grants/Research Funding); Agenus Inc. – Investigator(Grants/Research Funding); AiCuris GmbH & Co. KG – Investigator(Grants/Research Funding); Almirall – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Bayer – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding); Demira – Investigator(Grants/Research Funding); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foamix Pharmaceuticals Ltd – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Genocea Biosciences – Investigator(Grants/Research Funding); GlaxoSmithKline – Speaker(Honoraria); Glenmark Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); IQVIA – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Menlo Therapeutics Inc. – Investigator(Grants/Research Funding); Merck & Co., Inc – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); Nycomed Amersham – Investigator(Grants/Research Funding); Parexel – Investigator(Grants/Research Funding); Quintiles Pharma – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Trevi Therapeutics – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding); Vical Incorporated – Investigator(Grants/Research Funding);